Navigation Links
Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
Date:2/4/2008

ANN ARBOR, Mich., Feb. 4 /PRNewswire/ -- Pfizer's loss of some top talent, including Lipitor pioneer Dr. Bob Sliskovic, is the gain of two Michigan companies teaming to help speed research to fight bone diseases such as multiple myeloma, metastatic bone disease, rheumatoid arthritis and osteoporosis.

Velcura Therapeutics President and CEO Michael W. Long, PhD, announced his biotechnology company will work with Dr. Sliskovic and International Discovery Sourcing Consultants, LLC (IDSC), on the design and sourcing of medicinal chemistry data for its second generation and new bone therapy molecules. "IDSC brings added drug discovery leadership, experienced vendors and project managers as we begin our clinical trial this year for VEL-0230, a new drug that stimulates bone formation and inhibits bone loss," said Long.

"We offer in-depth support for scientific programs and also welcome a long-term partnership with firms like Velcura that are outsourcing," said IDSC President and CEO Mark Creswell. "The pharmaceutical industry experts joining us from Pfizer have 17-30 years of experience; we have chaired multiple projects that moved drug candidates into the clinic," he added. "Bob Sliskovic, for example, was responsible for the development of some 30 clinical candidates, including Lipitor."

Dr. Sliskovic, who was featured in the Dec. 11, 2007 Wall Street Journal, now dreams of being involved in another blockbuster like Lipitor. The work that he is doing now with IDSC could help Velcura to develop a treatment to help millions of individuals suffering from bone diseases like Osteoporosis, which is second to heart disease as a world health problem.

About Velcura Therapeutics(R), Inc.

Velcura Therapeutics Inc. is an early-stage biotechnology company headquartered in Ann Arbor, Michigan. Velcura's research focus is to better understand human bone disease and to discover novel therapeutics that restore bone health. Velcura develops highly
'/>"/>

SOURCE Velcura Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
3. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
4. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
5. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
6. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
7. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
8. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
9. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
10. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 Stronger ... healthcare, construction, finance and consumer electronics will help ... reason, industry research firm IBISWorld has added a ... its growing industry report collection. , The Biometrics ... for biometric technologies such as fingerprint, iris, retina ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Ardelyx, ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... quarter 2014 financial results on Thursday, November 6, ... will host a live conference call and webcast ... results and provide a business update. ...
(Date:10/30/2014)... Rancho BioSciences , the scientific data ... public data source TCGA for several of ... is now available for other oncology groups. ... data sources for their Pharma, Government and academic clients ... that becomes more easily accessible. Rancho advises their ...
(Date:10/30/2014)... 2014 Grace Century portfolio project, Provia ... Chairman of the Board, to the National Stem Cell ... was made by the Ministry of Health on behalf of ... , More than a year after Bahamian Parliament passed ... Minister Perry Christie said the government has completed the accompanying ...
Breaking Biology Technology:Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3
... amounts are in U.S. dollars , ... AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: ... and oncology, announces that it has completed the transaction ... Cowen Healthcare Royalty Partners, L.P. ("CHRP") relating to AEterna ...
... Dec. 3 Medarex, Inc.,(Nasdaq: MEDX ) announced today ... Conference at 3:30 p.m. Eastern Time on Wednesday,December 10, 2008. The ... Relations section of the Medarex website at www.medarex.com . An,archived ... About Medarex , ...
... When it comes to the health of their,children and even ... possible about health and medicine. With the many different,medicines out there, ... is taking,what and the dangers of drug reactions, interactions and side ... ) , In fact, ...
Cached Biology Technology:AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 2AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 3Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety 2
(Date:10/30/2014)... 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it ... and developmental harm. New consensus guidelines for toxicity ... and biological characteristics of these novel biopharmaceuticals are ... peer-reviewed journal from Mary Ann Liebert, Inc. ... the Nucleic Acid Therapeutics website until ...
(Date:10/30/2014)... researchers have developed a suite of technologies that can ... which has applications in everything from search and rescue ... developed a platform for computer-mediated communication between humans and ... interpreting dogs, behavioral signals and sending them clear and ... assistant professor of computer science at NC State and ...
(Date:10/30/2014)...  Securus Technologies, a leading provider of ... public safety, investigation, corrections and monitoring, announced ... to its THREADS™ product, which utilizes sophisticated ... and focused leads for investigators. ... through identifying and delivering solutions serving the ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2New tech aims to improve communication between dogs and humans 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2
... clear plastic cube, an inch or so across, just big ... sophisticated sensors and software, researchers can precisely control the light, ... Dong an Iowa State University assistant professor of electrical ... associate of the U.S. Department of Energy,s Ames Laboratory ...
... flies, Johns Hopkins scientists have decoded the activity of ... and where to branch so that they reach and ... counterparts are known to have signaling roles in immunity, ... broad implications for human disease research. A report of ...
... Alzheimer,s disease and related disorders, making them the largest ... observed in Alzheimer,s disease result from the accumulation of ... We know that obesity, a major risk factor in ... increases the risk of dementia during the aging process. ...
Cached Biology News:Iowa State computer, electrical engineers working to help biologists cope with big data 2Iowa State computer, electrical engineers working to help biologists cope with big data 3Molecular '2-way radio' directs nerve cell branching and connectivity 2Molecular '2-way radio' directs nerve cell branching and connectivity 3Detrimental effect of obesity on lesions associated with Alzheimer's disease 2
Request Info...
... Source: E. coli containing a clone of ... Description: Topoisomerase II alters the topological state ... helix through a transient break which generates a ... of its double-stranded DNA passage mechanism, the enzyme ...
Request Info...
... The Neural Stem Cell Expansion Kit - ... vitro neural stem cell expansion as neurospheres ... a specially formulated N-2 Plus Media Supplement, which ... (Johe, K.K. et al . (1996) Genes ...
Biology Products: